Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease Patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease Patients ; volume:9 ; number:1 ; day:16 ; month:4 ; year:2019 ; pages:1-11 ; date:12.2019
Scientific reports ; 9, Heft 1 (16.4.2019), 1-11, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
D’Andrea, Giovanni
Pizzolato, Gilberto
Gucciardi, Antonina
Stocchero, Matteo
Giordano, Giuseppe
Baraldi, Eugenio
Leon, Alberta
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-42535-w
- URN
-
urn:nbn:de:101:1-2019042820551004336755
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- D’Andrea, Giovanni
- Pizzolato, Gilberto
- Gucciardi, Antonina
- Stocchero, Matteo
- Giordano, Giuseppe
- Baraldi, Eugenio
- Leon, Alberta
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biogene Amine in der Pathogenese des Morbus Parkinson
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Metabolic profiling reveals circulating biomarkers associated with incident and prevalent Parkinson’s disease
Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease
Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease
Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease
Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
Parkinson
Parkinson
Gender-dependent effect of coffee consumption on tremor severity in de novo Parkinson’s disease
Biogene Amine in der Pathogenese des Morbus Parkinson
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Metabolic profiling reveals circulating biomarkers associated with incident and prevalent Parkinson’s disease
Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease
Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease
Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease
Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
Parkinson
Parkinson
Gender-dependent effect of coffee consumption on tremor severity in de novo Parkinson’s disease
Biogene Amine in der Pathogenese des Morbus Parkinson
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Metabolic profiling reveals circulating biomarkers associated with incident and prevalent Parkinson’s disease
Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease
Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease
Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease
Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
Parkinson
Parkinson